Clinical trial
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who…
NCT00308438 · Shire, Industry · Completed
Key facts
| NCT number | NCT00308438 |
|---|---|
| Title | Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 |
| Official title | An Open Label Extension Study of the Safety and Efficacy of ALX-0600 in Subjects With Crohn's Disease Who Completed the Pilot Study Protocol CL0600-008 |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Teduglutide (ALX-0600) |
| Enrollment | 67 |
| Start date | Mar 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Mar 29, 2006 |
| Last update posted | May 14, 2021 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: